| __timestamp | Grifols, S.A. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 660772000 | 2999000 |
| Thursday, January 1, 2015 | 736435000 | 10393000 |
| Friday, January 1, 2016 | 775266000 | 15994000 |
| Sunday, January 1, 2017 | 860348000 | 26975000 |
| Monday, January 1, 2018 | 814775000 | 39509000 |
| Tuesday, January 1, 2019 | 942821000 | 48869000 |
| Wednesday, January 1, 2020 | 985616000 | 42510000 |
| Friday, January 1, 2021 | 1061508000 | 46105000 |
| Saturday, January 1, 2022 | 1190423000 | 50513000 |
| Sunday, January 1, 2023 | 1254234000 | 51292000 |
Data in motion
In the world of biotechnology and pharmaceuticals, operational efficiency is key. Grifols, S.A., a global leader in plasma-derived medicines, and Wave Life Sciences Ltd., a cutting-edge genetic medicine company, offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Grifols, S.A. has seen a consistent increase in SG&A expenses, growing by approximately 90%. This steady rise reflects the company's expansion and increased operational activities, peaking in 2023.
Conversely, Wave Life Sciences Ltd. has experienced a more modest increase of around 1,600% in the same period, indicative of its growth phase and strategic investments in research and development.
This comparison highlights the diverse strategies and growth trajectories of these two industry players.
Comparing SG&A Expenses: AbbVie Inc. vs Grifols, S.A. Trends and Insights
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Grifols, S.A.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
BioMarin Pharmaceutical Inc. vs Grifols, S.A.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Grifols, S.A.
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Who Optimizes SG&A Costs Better? Grifols, S.A. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights